2[1]De Lucia D,Papa ML,Ammendola F,et al. Association of elevated levels of prothrombin fragment 1+2 and Arg506 to Gln mutation in patients with a history of ischemic stroke[J]. J Neurosurg Sci,1999,43:45.
3[2]Kenet G,Sadetzki S,Murad H,et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children[J]. Stroke,2000,31:1283.
4[3]Simioni P,Ronde H de,Prandoni P,et al. Ischemic stroke in young patients with activated protein C resistance:a report of three cases belonging to three different kindreds[J]. Stroke,1995,26:885.
5[4]Lu Y,Zhao Y,Liu G,et al. Factor V gene G1691A mutation,prothrombin gene G20210A mutation,and MTHFR gene C677T mutation are not risk factors for pulmonary thromboembolism in Chinese population. Thromb Res,2002,106:7.
6Mesotten D, van den Berghe G. Clinical potential of insulin therapy in critically ill patients. Drugs,2003,63:625-636.
7McCowen KC,Malhotra A,Bistrian BR. Stress-induced hyperglycemia. Cdt Care Clin,2001,17:107-124.
8van den Berghe G, Wouters P, Weekers F,et al. Intensive insulin therapy in critically ill patients. N Eng J Med,2001,345:1359-1367.
9Umpierrez GE,Hsaacs SD,Bazargan N,et al. Hyperglycemia: an independent marker of in hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab,2002,87:978-982.
10Frankenfield DC, Omert LA, Badellino MM,et al. Correlation between measured energy expenditure and clinically obtained variables in trauma and sepsis patients. J Parenter Enteral Nutr, 1994,18:398-403.
